[HTML][HTML] Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease

I Beltran-Hortelano, V Alcolea, M Font… - Bioorganic & medicinal …, 2022 - Elsevier
Chagas disease (CD) is a centenarian neglected parasitosis caused by the protozoan
Trypanosoma cruzi (T. cruzi). Despite the continuous efforts of many organizations and …

Recent developments in free energy calculations for drug discovery

E King, E Aitchison, H Li, R Luo - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
The grand challenge in structure-based drug design is achieving accurate prediction of
binding free energies. Molecular dynamics (MD) simulations enable modeling of …

Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets

M Laureano de Souza, TJWJD Lapierre… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Chagas disease (CD) imposes social and economic burdens, yet the available
treatments have limited efficacy in the disease's chronic phase and cause serious adverse …

Computational identification of potential anti-inflammatory natural compounds targeting the p38 mitogen-activated protein kinase (MAPK): Implications for COVID-19 …

SO Asiedu, SK Kwofie, E Broni, MD Wilson - Biomolecules, 2021 - mdpi.com
Severely ill coronavirus disease 2019 (COVID-19) patients show elevated concentrations of
pro-inflammatory cytokines, a situation commonly known as a cytokine storm. The p38 …

Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles

VC Santos, PG Leite, LH Santos, PG Pascutti… - European Journal of …, 2023 - Elsevier
Over 110 years after the first formal description of Chagas disease, the trypanocidal drugs
thus far available have limited efficacy and several side effects. This encourages the search …

Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study

RJ Khan, RK Jha, E Singh, M Jain… - Journal of …, 2022 - Taylor & Francis
The recent COVID-19 pandemic caused by SARS-CoV-2 has recorded a high number of
infected people across the globe. The virulent nature of the virus makes it necessary for us to …

Structure-based virtual screening, molecular docking, molecular dynamics simulation and pharmacokinetic modelling of cyclooxygenase-2 (COX-2) inhibitor for the …

M Yadav, M Abdalla, M Madhavi, I Chopra… - Molecular …, 2022 - Taylor & Francis
Colorectal cancer is the third most frequent cause of cancer worldwide and is more
prevalent in older individuals of all ages. The recent statistics from World Health …

[HTML][HTML] Computational approaches towards the discovery and optimisation of cruzain inhibitors

VC Santos, RS Ferreira - Memórias do Instituto Oswaldo Cruz, 2022 - SciELO Brasil
The need to develop safer and more efficacious drugs to treat Chagas disease has
motivated the search for cruzain inhibitors. Cruzain is the recombinant, truncated version of …

Understanding structure–activity relationships for trypanosomal cysteine protease inhibitors by simulations and free energy calculations

LH Santos, BJ Waldner, JE Fuchs… - Journal of Chemical …, 2018 - ACS Publications
The protozoan cysteine proteases cruzain in Trypanosoma cruzi and rhodesain in
Trypanosoma brucei are therapeutic targets for Chagas disease and Human African …

The Power of Molecular Dynamics Simulations and Their Applications to Discover Cysteine Protease Inhibitors

IJ dos Santos Nascimento… - Mini Reviews in …, 2024 - ingentaconnect.com
A large family of enzymes with the function of hydrolyzing peptide bonds, called peptidases
or cysteine proteases (CPs), are divided into three categories according to the peptide chain …